/
PAVM
$5.36+$0.31 (+6.14%)live
Held · Bookmarked
0 · 0
portfolios · users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Market cap
$36.2M
7M shares
52-week range
$3.85 – $28.44
6% from low
Sector
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NASDAQ
CS
Borrow rate
33.56%
Hard to borrow
Price (6 mo)
Loading chart…
Change$-2811.64
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $500.0K | $377.0K | $2.5M | $3.0M | $71.0K |
| Cost of revenue | $9.8K | $14.2K | $0 | $585.0K | $3.6M | $6.4M | $6.0M | $323.0K |
| Gross profit | −$9.8K | −$14.2K | $0 | −$85.0K | −$3.2M | −$4.0M | −$3.0M | −$252.0K |
| Gross margin | — | — | — | -17.0% | -858.6% | -161.8% | -101.6% | -354.9% |
| R&D | $4.3M | $6.6M | $11.0M | $19.8M | $25.3M | $14.3M | $5.9M | $4.49B |
| Operating income | −$10.6M | −$14.3M | −$23.4M | −$54.4M | −$91.1M | −$68.8M | −$44.5M | −$21.8M |
| EBITDA | −$12.1M | −$16.7M | −$23.3M | −$55.9M | −$99.5M | −$75.7M | $29.7M | −$2.3M |
| Net income | −$18.0M | −$15.9M | −$34.3M | −$50.3M | −$89.0M | −$64.2M | $39.8M | $401.0K |
| Net margin | — | — | — | -10069.4% | -23602.9% | -2617.3% | 1328.6% | 564.8% |
| EPS (diluted) | -378.78 | -249.27 | -327.91 | -293.92 | -450.95 | -274.92 | 14.88 | -5.63 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $340000 | $-3.14 | $-3.85–$-2.43 | 1 |
| 2027 | $652500 | $-1.28 | $-1.57–$-0.99 | 1 |
Forward consensus · source: Financial Modeling Prep
Peer comparison
PAVmed Inc. Common Stock
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
www.pavmed.com- Employees
- 41
- IPO / List date
- Apr 28, 2016
- HQ
- NEW YORK, NY
Held by traders on TradeandTell
No one on the platform currently holds PAVM.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in PAVM as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2026-01-02 | 1-for-30reverse |
| 2023-12-07 | 1-for-15reverse |
Recent trades on TradeandTell
No one on the platform has traded PAVM yet.
